In order to examine whether the poor survival is due to high ST14/Prss14 expression, and not due to the absence of HER2 in TN, we tried to compare the survival of ST14/Prss14high and ST14/Prss14low populations in the HER2 and TN breast cancer groups. This evidence concerns the gene ERBB2 and breast carcinoma.